101 related articles for article (PubMed ID: 23025322)
1. Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR.
García-Mayoral MF; Canales A; Díaz D; López-Prados J; Moussaoui M; de Paz JL; Angulo J; Nieto PM; Jiménez-Barbero J; Boix E; Bruix M
ACS Chem Biol; 2013 Jan; 8(1):144-51. PubMed ID: 23025322
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
Torrent M; Nogués MV; Boix E
J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
[TBL] [Abstract][Full Text] [Related]
3. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
Singh A; Batra JK
Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
[TBL] [Abstract][Full Text] [Related]
4. The (1)H, (13)C, (15)N resonance assignment, solution structure, and residue level stability of eosinophil cationic protein/RNase 3 determined by NMR spectroscopy.
Laurents DV; Bruix M; Jiménez MA; Santoro J; Boix E; Moussaoui M; Nogués MV; Rico M
Biopolymers; 2009 Dec; 91(12):1018-28. PubMed ID: 19189375
[TBL] [Abstract][Full Text] [Related]
5. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form.
Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S
J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
[TBL] [Abstract][Full Text] [Related]
7. Characterization of molecular interactions between eosinophil cationic protein and heparin.
Fan TC; Fang SL; Hwang CS; Hsu CY; Lu XA; Hung SC; Lin SC; Chang MD
J Biol Chem; 2008 Sep; 283(37):25468-25474. PubMed ID: 18593710
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of the native and the ligand-bound structures of eosinophil cationic protein: network of hydrogen bonds at the catalytic site.
Sanjeev BS; Vishveshwara S
J Biomol Struct Dyn; 2005 Jun; 22(6):657-72. PubMed ID: 15842171
[TBL] [Abstract][Full Text] [Related]
9. NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics.
García-Mayoral MF; Moussaoui M; de la Torre BG; Andreu D; Boix E; Nogués MV; Rico M; Laurents DV; Bruix M
Biophys J; 2010 Jun; 98(11):2702-11. PubMed ID: 20513415
[TBL] [Abstract][Full Text] [Related]
10. Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.
Torrent M; Pulido D; de la Torre BG; García-Mayoral MF; Nogués MV; Bruix M; Andreu D; Boix E
J Med Chem; 2011 Jul; 54(14):5237-44. PubMed ID: 21696142
[TBL] [Abstract][Full Text] [Related]
11. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.
Mallorquí-Fernández G; Pous J; Peracaula R; Aymamí J; Maeda T; Tada H; Yamada H; Seno M; de Llorens R; Gomis-Rüth FX; Coll M
J Mol Biol; 2000 Jul; 300(5):1297-307. PubMed ID: 10903870
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR.
Montserret R; Aubert-Foucher E; McLeish MJ; Hill JM; Ficheux D; Jaquinod M; van der Rest M; Deléage G; Penin F
Biochemistry; 1999 May; 38(20):6479-88. PubMed ID: 10350466
[TBL] [Abstract][Full Text] [Related]
14. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
Gandhi NS; Freeman C; Parish CR; Mancera RL
Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of ECP-heparin interaction: a novel molecular model.
Hung TJ; Tomiya N; Chang TH; Cheng WC; Kuo PH; Ng SK; Lien PC; Lee YC; Chang MD
PLoS One; 2013; 8(12):e82585. PubMed ID: 24349317
[TBL] [Abstract][Full Text] [Related]
16. The structure of truncated recombinant human bile salt-stimulated lipase reveals bile salt-independent conformational flexibility at the active-site loop and provides insights into heparin binding.
Moore SA; Kingston RL; Loomes KM; Hernell O; Bläckberg L; Baker HM; Baker EN
J Mol Biol; 2001 Sep; 312(3):511-23. PubMed ID: 11563913
[TBL] [Abstract][Full Text] [Related]
17. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
[TBL] [Abstract][Full Text] [Related]
18. NMR studies of the secondary structure in solution and the steroid binding site of delta5-3-ketosteroid isomerase in complexes with diamagnetic and paramagnetic steroids.
Zhao Q; Abeygunawardana C; Mildvan AS
Biochemistry; 1997 Mar; 36(12):3458-72. PubMed ID: 9131995
[TBL] [Abstract][Full Text] [Related]
19. Membrane-bound carboxypeptidase E facilitates the entry of eosinophil cationic protein into neuroendocrine cells.
Wu CM; Chang HT; Chang MD
Biochem J; 2004 Sep; 382(Pt 3):841-8. PubMed ID: 15233624
[TBL] [Abstract][Full Text] [Related]
20. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
